Barat Chandana, Simpson LeRone, Breslow Esther
Department of Biochemistry, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA.
Biochemistry. 2004 Jun 29;43(25):8191-203. doi: 10.1021/bi0400094.
These studies were aimed at an initial characterization of the human vasopressin precursor and the evaluation of factors leading to misfolding by the pathological 87STOP mutation. This mutation deletes the precursor's glycosylated copeptin segment, which has been considered unnecessary for folding, and the last seven neurophysin residues. We investigated the role in folding of the last seven neurophysin residues by comparing the properties of the 87STOP precursor and its derivative neurophysin with those of the corresponding wild-type proteins from which copeptin had been deleted, leading to the following conclusions. First, despite modulating effects on several protein properties, the last seven neurophysin residues do not make a significant net thermodynamic contribution to precursor folding; stabilities of the mutant and wild-type precursors to both guanidine denaturation and redox buffer unfolding are similar, as are in vitro folding rates. Second, the monomeric forms of both precursors are unstable and predicted to fold inefficiently at physiological pH and temperature, as evidenced by precursor behavior in redox buffers and by thermodynamic calculations. Third, both precursors are significantly less stable than the bovine oxytocin precursor. These results, together with earlier studies elsewhere of vasopressin precursor behavior within rat neurons, are shown to represent a self-consistent argument for a role for glycosylated copeptin in vasopressin precursor folding in vivo, copeptin most probably assisting refolding by facilitating interaction of misfolded monomers with the calnexin/calreticulin system. This hypothesis provides an explanation for the absence of copeptin in the more stable oxytocin precursor and suggests that the loss of copeptin contributes to 87STOP pathogenicity. Reported cell culture studies of rat precursor folding are also discussed in this context. Most generally, the results emphasize the significance of monomer stability in the folding pathways of oligomeric proteins.
这些研究旨在对人血管加压素前体进行初步表征,并评估导致病理性87STOP突变错折叠的因素。该突变删除了前体的糖基化 copeptin 片段(该片段被认为对折叠没有必要)以及最后七个神经垂体素残基。我们通过比较87STOP前体及其衍生的神经垂体素与相应缺失了copeptin的野生型蛋白的特性,研究了最后七个神经垂体素残基在折叠中的作用,得出以下结论。首先,尽管对几种蛋白质特性有调节作用,但最后七个神经垂体素残基对前体折叠没有显著的净热力学贡献;突变体和野生型前体对胍变性和氧化还原缓冲液展开的稳定性相似,体外折叠速率也相似。其次,两种前体的单体形式都不稳定,预计在生理pH和温度下折叠效率低下,氧化还原缓冲液中前体的行为以及热力学计算都证明了这一点。第三,两种前体的稳定性都明显低于牛催产素前体。这些结果,连同其他地方早期对大鼠神经元内血管加压素前体行为的研究,表明糖基化copeptin在体内血管加压素前体折叠中起作用是一个自洽的观点,copeptin很可能通过促进错误折叠的单体与钙连蛋白/钙网蛋白系统的相互作用来协助重折叠。这一假设解释了更稳定的催产素前体中不存在copeptin的现象,并表明copeptin的缺失促成了87STOP的致病性。本文还在这一背景下讨论了已报道的大鼠前体折叠的细胞培养研究。最普遍的是,这些结果强调了单体稳定性在寡聚蛋白折叠途径中的重要性。